E Horst

Summary

Country: Germany

Publications

  1. ncbi Radiation therapy approach in gliomatosis cerebri--case reports and literature review
    E Horst
    Department of Radiation Oncology, University of Munster, School of Medicine, Germany
    Acta Oncol 39:747-51. 2000
  2. ncbi Accelerated radiochemotherapy in pancreatic cancer is not necessarily related to a pathologic pancreatic function decline in the early period
    Eckehard Horst
    Department of Radiation Oncology, University of Munster, Munster, Germany
    Int J Radiat Oncol Biol Phys 52:304-9. 2002
  3. ncbi Conformal therapy for pancreatic cancer: variation of organ position due to gastrointestinal distention--implications for treatment planning
    Eckehard Horst
    Department of Radiation Oncology, University of Munster, Albert Schweitzer Strasse 33, 48129 Munster, Germany
    Radiology 222:681-6. 2002
  4. ncbi Functional evaluation of the human pancreas before and in the early period after hyperfractionated accelerated radiochemotherapy
    Eckehard Horst
    Department of Radiation Oncology, University of Munster, Germany
    Front Radiat Ther Oncol 37:17-25. 2002
  5. ncbi CT simulation in nodal positive breast cancer
    E Horst
    Department of Radiation Oncology, University of Munster, Germany
    Strahlenther Onkol 177:511-6. 2001
  6. ncbi The multicentric epitheloid hemangioendothelioma of bone: a case example and review of the literature
    G Gosheger
    Department of Orthopaedics, Westfalische Wilhelms Universitat, Albert Schweitzer Strasse 33, 48149 Munster, Germany
    J Cancer Res Clin Oncol 128:11-8. 2002
  7. ncbi CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy
    Oliver Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, 48129 Munster, Germany
    Anticancer Res 23:835-40. 2003
  8. ncbi The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck
    Oliver Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, Albert Schweitzer Str 33, 48129 Munster, Germany
    Anticancer Res 23:907-11. 2003
  9. ncbi Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Int J Radiat Oncol Biol Phys 57:90-7. 2003
  10. ncbi Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Anticancer Res 25:1523-30. 2005

Detail Information

Publications10

  1. ncbi Radiation therapy approach in gliomatosis cerebri--case reports and literature review
    E Horst
    Department of Radiation Oncology, University of Munster, School of Medicine, Germany
    Acta Oncol 39:747-51. 2000
    ..Survival from onset of symptoms was 23.8 months (range 8-42). Considerable variation in the natural course of the disease precludes conclusions regarding the impact of radiation therapy on survival...
  2. ncbi Accelerated radiochemotherapy in pancreatic cancer is not necessarily related to a pathologic pancreatic function decline in the early period
    Eckehard Horst
    Department of Radiation Oncology, University of Munster, Munster, Germany
    Int J Radiat Oncol Biol Phys 52:304-9. 2002
    ..To evaluate the functional effects of ionizing radiation in patients with unresectable pancreatic cancer in the early period after accelerated radiochemotherapy (ART)...
  3. ncbi Conformal therapy for pancreatic cancer: variation of organ position due to gastrointestinal distention--implications for treatment planning
    Eckehard Horst
    Department of Radiation Oncology, University of Munster, Albert Schweitzer Strasse 33, 48129 Munster, Germany
    Radiology 222:681-6. 2002
    ..To quantify nonrespiratory organ motion in the pancreatic region and its effect on clinical target volume...
  4. ncbi Functional evaluation of the human pancreas before and in the early period after hyperfractionated accelerated radiochemotherapy
    Eckehard Horst
    Department of Radiation Oncology, University of Munster, Germany
    Front Radiat Ther Oncol 37:17-25. 2002
  5. ncbi CT simulation in nodal positive breast cancer
    E Horst
    Department of Radiation Oncology, University of Munster, Germany
    Strahlenther Onkol 177:511-6. 2001
    ..The choice is depending on the technical equipment which is available and the clinical situation. The CT simulation of a non-monoisocentric technique was evaluated in terms of accuracy and reproducibility...
  6. ncbi The multicentric epitheloid hemangioendothelioma of bone: a case example and review of the literature
    G Gosheger
    Department of Orthopaedics, Westfalische Wilhelms Universitat, Albert Schweitzer Strasse 33, 48149 Munster, Germany
    J Cancer Res Clin Oncol 128:11-8. 2002
    ..Palliative radiotherapy should only be used for a non-resectable tumour or in metastatic disease. Chemotherapy is not a treatment option...
  7. ncbi CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy
    Oliver Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, 48129 Munster, Germany
    Anticancer Res 23:835-40. 2003
    ..The aim of this study was to determine the value of CA 19-9 in therapy monitoring and follow-up of locally advanced pancreatic cancer treated by radiochemotherapy...
  8. ncbi The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck
    Oliver Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, Albert Schweitzer Str 33, 48129 Munster, Germany
    Anticancer Res 23:907-11. 2003
    ..This study examines the value of squamous cell cancer (SCC) antigen in patients irradiated for locally advanced cancer of the head and neck...
  9. ncbi Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Int J Radiat Oncol Biol Phys 57:90-7. 2003
    ..To determine the predictive value of carbohydrate antigen (CA) 19-9 in pancreatic cancer treated with radiochemotherapy...
  10. ncbi Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Anticancer Res 25:1523-30. 2005
    ..In locally advanced carcinoma of the exocrine pancreas combined radiochemotherapy has been established as a standard treatment...